CompletedPhase 1NCT04229303
Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects
Studying Allergic bronchopulmonary aspergillosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Zambon SpA
- Principal Investigator
- Sukh Dave Singh, Prof, MD,The Medicine Evaluation Unit (MEU) Ltd, Langley building,
- Intervention
- Voriconazole inhaled(drug)
- Enrollment
- 58 enrolled
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2020 – 2020
Study locations (1)
- Medicines Evaluation Unit Ltd. (MEU), Manchester, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04229303 on ClinicalTrials.govOther trials for Allergic bronchopulmonary aspergillosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07362667A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPAQianfoshan Hospital
- RECRUITINGNCT07362693A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPAQianfoshan Hospital
- RECRUITINGNCT07530770Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary AspergillosisQianfoshan Hospital
- RECRUITINGNCT07493629Immune Status and Disease Control of Inflammatory Airway DiseasesFirst Affiliated Hospital of Ningbo University
- RECRUITINGNCT07313904Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and BronchiectasisFirst Affiliated Hospital of Ningbo University
- RECRUITINGNCT07040332Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary AspergillosisQianfoshan Hospital
- RECRUITINGPHASE2NCT06244979iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamineRadboud University Medical Center
- RECRUITINGPHASE3NCT06174922A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary AspergillosisPost Graduate Institute of Medical Education and Research, Chandigarh
See all trials for Allergic bronchopulmonary aspergillosis →